Navigation Links
Physician groups support comparative effectiveness provisions in proposed legislation
Date:7/13/2009

Washington, July 13, 2009 The American College of Physicians (ACP) today joined with two other physician groups to offer strong support for the Comparative Effectiveness Research (CER) provisions included in the Tri-Committee health reform bill about to be considered in the House. The Tri-Committee, which unveiled its proposed legislation on June 19, is made up of the House Ways and Means, Energy and Commerce, and Education and Labor Committees.

Today's support was provided in a letter to the chairmen and ranking members of the three committees. The organizations ACP, the American Academy of Family Physicians (AAFP) and the Society of General Internal Medicine (SGIM) represent more than 200,000 physicians who treat patients every day, many of whom have multiple chronic conditions.

"We know the value of having scientifically valid information available that permits physicians and their patients to make informed decisions on the most effective and appropriate treatment in individual cases. We also firmly believe that patient care will benefit if coverage decisions are informed by the best available science, including evidence on the clinical effectiveness of different treatments," said Jim King, MD, FAAFP, board chair of AAFP, Joseph W. Stubbs, MD, FACP, president of ACP and Nancy Rigotti, MD, FACP, president of SGIM

"Comparative effectiveness research brings to the patient and physician the best chance of providing the right treatment to each patient in the most safe and effective manner. We know that better information on which treatments are most effective leads to better patient outcomes, less suffering, and more efficient use of limited healthcare resources. Moreover, we agree with the approach of your bill, which makes clear the importance that this information must be the result of scientifically valid research, emanating from a trusted source and dedicated solely to the development of comparative effectiveness research based on the best available science and through a transparent process," the letter continued.

"We have great respect for the incredibly hard work your committees have undertaken in the enormous and complex objective of healthcare reform. As the bill moves through the House and eventually into a Conference Committee with the Senate, we urge you to hold fast to your positions on CER that will maintain it as a scientifically-based research initiative designed to benefit patients. CER should not be subjected to arbitrary legislative limits on use that could harm patients by denying them, their physicians, and their health plans with access to the best scientific evidence to improve the care patients receive."

"Thank you for considering our views. We look forward to continuing to work with you in the weeks and months ahead as you endeavor to provide the American people with a healthcare system, with CER, that will work to their great benefit," the letter ended.


'/>"/>

Contact: David Kinsman
dkinsman@acponline.org
202-261-4554
American College of Physicians
Source:Eurekalert

Related medicine news :

1. Increased distance to physician associated with thicker skin cancer at diagnosis
2. Broad-based group of physicians calls for improvement in stroke treatment
3. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
4. Psychiatrists are the least religious of all physicians
5. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
6. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
7. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. Scientists, physicians present latest findings in personalized cancer treatment and prevention
10. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
11. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. ... for the majority of skin cancer deaths. More than 10,000 people are expected to die ... diagnosis is 62, it is the one of the most commonly diagnosed cancers in young ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the dentists ... dentistry is a fast-growing field as more patients are discovering the many different ways ... about the options currently available to them and which ones might work for their ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... Hills, CA (PRWEB) , ... April 29, 2016 , ... ... of devices and products for the head and neck/ear, nose and throat specialty, has ... Device , The KOTLER NASAL AIRWAY™ is a newly patented safety device ...
(Date:4/29/2016)... OR (PRWEB) , ... April 29, 2016 , ... For ... dinner as the meal to miss. That was among the many new lifestyle diet ... on a recent Sharon Kleyne Hour® Power of Water® radio show. Bonny and Lawrence ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 2016 Acquisition Expands the ... Development Capabilities in North America ... Indegene ( http://www.indegene.com ), a ... of Skura Corporation,s life science business. Skura,s SFX ... enablement technology for life science organizations and delivers ...
(Date:4/29/2016)... , April 29, 2016 ... Directeur Financier Sanofi, leader ... publie ses résultats pour le premier ... Groupe, Jérôme Contamine, commente les résultats ... les perspectives pour le reste de ...
(Date:4/29/2016)... 29, 2016 Glycotope GmbH, a ... announces the appointment of Dr. Alfredo Zurlo ... an oncologist with many years clinical experience and a ... His last role was at Mologen AG where he ... Board. Previously Dr. Zurlo held various positions at F ...
Breaking Medicine Technology: